BRAFV600E immunohistochemistry in conjunction with mismatch repair status predicts survival in patients with colorectal cancer.
about
A further investigation of combined mismatch repair and BRAFV600E mutation specific immunohistochemistry as a predictor of overall survival in colorectal carcinomaBRAF V600E immunohistochemistry is reliable in primary and metastatic colorectal carcinoma regardless of treatment status and shows high intratumoral homogeneityImmunohistochemistry with the anti-BRAF V600E (VE1) antibody: impact of pre-analytical conditions and concordance with DNA sequencing in colorectal and papillary thyroid carcinoma.KRAS and BRAF gene mutations and DNA mismatch repair status in Chinese colorectal carcinoma patientsImmunohistochemistry for myc predicts survival in colorectal cancer.Combination of microsatellite instability and BRAF mutation status for subtyping colorectal cancer.The Lymphocyte-to-Monocyte Ratio is a Superior Predictor of Overall Survival in Comparison to Established Biomarkers of Resectable Colorectal CancerMedullary colorectal carcinoma revisited: a clinical and pathological study of 102 cases.Approach to Lynch Syndrome for the Gastroenterologist.Colorectal cancer resection in the Australian nonagenarian patient.Mismatch repair deficiency as a prognostic factor in mucinous colorectal cancer.Frequent BRAF mutation in early-onset colorectal cancer in Taiwan: association with distinct clinicopathological and molecular features and poor clinical outcome.Current Tissue Molecular Markers in Colorectal Cancer: A Literature Review.Immunohistochemistry with Anti-BRAF V600E (VE1) Mouse Monoclonal Antibody is a Sensitive Method for Detection of the BRAF V600E Mutation in Colon Cancer: Evaluation of 120 Cases with and without KRAS Mutation and Literature Review.Improving diagnosis, prognosis and prediction by using biomarkers in CRC patients (Review).[Molecular pathology of colorectal cancer].Prognostic value of the combination of microsatellite instability and mutation in colorectal cancer
P2860
Q34084086-A412196C-CA27-401D-B2D3-99F886B7760FQ34206112-6774336D-D0A9-4A81-B5BF-D71B2320D001Q34520869-98AF0198-E4A1-43C6-AF11-81191B477180Q35045790-B38E7E2E-91CD-4862-8F37-DCACC70DCACDQ35087649-65494D51-F87A-4DCF-97FE-E23EFFA42505Q36086848-B69920FA-B192-4ED7-B26E-844D806EDAA4Q37634006-79F3F9A6-D46E-4738-B773-A0AF9DCD7126Q38311970-E5B51DEA-4E27-479B-9754-BAF20C14ADC6Q39042915-9205CC78-1EDD-41B6-9310-AE25AFD06046Q39647173-8D80D43B-C930-40F6-9368-E322AC90385FQ40975682-86884B45-6298-4FD3-B0A0-B87B2BA024BCQ41187085-ACFE2312-CD9D-47C6-9889-CC154F22BFB6Q47094355-0B9AD24D-50C6-4A6D-8242-D0CA5AF528D6Q47614611-56802CCC-D480-487E-8513-77D67A6B3ACDQ51732351-3E6F4AB4-7AC2-4D73-BA04-7C064A31666CQ53581884-778A20CC-7AD7-4A28-8B8E-526861DFCD0EQ57491315-6D982D22-D6CD-41BD-BCD7-79F9D3127484
P2860
BRAFV600E immunohistochemistry in conjunction with mismatch repair status predicts survival in patients with colorectal cancer.
description
2013 nî lūn-bûn
@nan
2013 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
BRAFV600E immunohistochemistry ...... tients with colorectal cancer.
@ast
BRAFV600E immunohistochemistry ...... tients with colorectal cancer.
@en
type
label
BRAFV600E immunohistochemistry ...... tients with colorectal cancer.
@ast
BRAFV600E immunohistochemistry ...... tients with colorectal cancer.
@en
prefLabel
BRAFV600E immunohistochemistry ...... tients with colorectal cancer.
@ast
BRAFV600E immunohistochemistry ...... tients with colorectal cancer.
@en
P2093
P2860
P1433
P1476
BRAFV600E immunohistochemistry ...... atients with colorectal cancer
@en
P2093
Adele Clarkson
Angela Chou
Christopher W Toon
Jillian Patterson
Joseph Chan
Keshani DeSilva
Loretta Sioson
Lucy Jankova
P2860
P2888
P304
P356
10.1038/MODPATHOL.2013.200
P577
2013-10-25T00:00:00Z
P5875
P6179
1028131238